Drugs / AMOXICILIN
Trials 0
Also used as a comparator or background therapy in 2 trials
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 11 trial | ||||||
| Phase 1 | NCT02143323 Comparator | Dec 2013 → Aug 2014 | — | Seoul National University Hospital | Completed | No outcome recorded |
| Phase 41 trial | ||||||
| Phase 4 | NCT03863249 Comparator | Feb 2019 → May 2022 | chronic periodontitis, primary bacterial infectious disease | University of Valencia | Completed | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Amoxicilin | “The antibiotic will be selected among AMOXICILIN, METRONIDAZOLE, AMOXICILIN + METRONIDAZOLE AND AZITROMYCIN.” NCT03863249 ↗1“Augmentin 3 tablets (Amoxicilin:clavualanate=2:1) bid, for 14days” NCT02143323 ↗ |